Baicalin target protein, Annexin A2, is a target of new antitumor drugs
Yoshio Kusakabe(Teikyo University), Hideaki Watanabe(Showa University)
Cited by 7
Related Papers
CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
|Cancer Medicine|2021|26
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma
|Translational Oncology|2021|26
Met-PET uptake index for total tumor resection: identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma
|Neurosurgical Review|2020|20
Microvasculature of Carotid Atheromatous Plaques: Hemorrhagic Plaques Have Dense Microvessels with Fenestrations to the Arterial Lumen
|Journal of Stroke and Cerebrovascular Diseases|2014|17